These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 22975713)

  • 1. Usefulness of the RISK-PCI score to predict stent thrombosis in patients treated with primary percutaneous coronary intervention for ST-segment elevation myocardial infarction: a substudy of the RISK-PCI trial.
    Mrdovic I; Savic L; Lasica R; Krljanac G; Asanin M; Brdar N; Djuricic N; Cvetinovic N; Marinkovic J; Perunicic J
    Heart Vessels; 2013 Jul; 28(4):424-33. PubMed ID: 22975713
    [TBL] [Abstract][Full Text] [Related]  

  • 2. SYNTAX score and the risk of stent thrombosis after percutaneous coronary intervention in patients with non-ST-segment elevation acute coronary syndromes: an ACUITY trial substudy.
    Yadav M; Généreux P; Palmerini T; Caixeta A; Madhavan MV; Xu K; Brener SJ; Mehran R; Stone GW
    Catheter Cardiovasc Interv; 2015 Jan; 85(1):1-10. PubMed ID: 24408084
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Which Intraprocedural Thrombotic Events Impact Clinical Outcomes After Percutaneous Coronary Intervention in Acute Coronary Syndromes?: A Pooled Analysis of the HORIZONS-AMI and ACUITY Trials.
    Wessler JD; Généreux P; Mehran R; Ayele GM; Brener SJ; McEntegart M; Ben-Yehuda O; Stone GW; Kirtane AJ
    JACC Cardiovasc Interv; 2016 Feb; 9(4):331-337. PubMed ID: 26803422
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intra-procedural stent thrombosis: a new risk factor for adverse outcomes in patients undergoing percutaneous coronary intervention for acute coronary syndromes.
    Brener SJ; Cristea E; Kirtane AJ; McEntegart MB; Xu K; Mehran R; Stone GW
    JACC Cardiovasc Interv; 2013 Jan; 6(1):36-43. PubMed ID: 23266233
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential 1-year clinical outcomes for ST-segment elevation myocardial infarction related to stent thrombosis or saphenous vein graft thrombosis.
    Arzamendi D; Ly HQ; Tanguay JF; Armero S; Jilaihawi H; Gallo R; Ibrahim R; L'Allier P; Blondeau L; Gosselin G; Gregoire J; Doucet S
    Catheter Cardiovasc Interv; 2013 Aug; 82(2):193-200. PubMed ID: 21805615
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The anatomic- and clinical-based NERS (new risk stratification) score II to predict clinical outcomes after stenting unprotected left main coronary artery disease: results from a multicenter, prospective, registry study.
    Chen SL; Han YL; Zhang YJ; Ye F; Liu HW; Zhang JJ; Xu B; Jiang TM; Zhou YJ; Lv SZ
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1233-41. PubMed ID: 24239199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Improved safety and reduction in stent thrombosis associated with biodegradable polymer-based biolimus-eluting stents versus durable polymer-based sirolimus-eluting stents in patients with coronary artery disease: final 5-year report of the LEADERS (Limus Eluted From A Durable Versus ERodable Stent Coating) randomized, noninferiority trial.
    Serruys PW; Farooq V; Kalesan B; de Vries T; Buszman P; Linke A; Ischinger T; Klauss V; Eberli F; Wijns W; Morice MC; Di Mario C; Corti R; Antoni D; Sohn HY; Eerdmans P; Rademaker-Havinga T; van Es GA; Meier B; Jüni P; Windecker S
    JACC Cardiovasc Interv; 2013 Aug; 6(8):777-89. PubMed ID: 23968698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impact of stent generation on 2-year clinical outcomes in ST-segment elevation myocardial infarction patients with multivessel disease who underwent culprit-only or multivessel percutaneous coronary intervention.
    Kim YH; Her AY; Jeong MH; Kim BK; Hong SJ; Kim JS; Ko YG; Choi D; Hong MK; Jang Y
    Catheter Cardiovasc Interv; 2020 Feb; 95(2):E40-E55. PubMed ID: 31423723
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absorb bioresorbable vascular scaffold versus everolimus-eluting metallic stent in ST-segment elevation myocardial infarction: 1-year results of a propensity score matching comparison: the BVS-EXAMINATION Study (bioresorbable vascular scaffold-a clinical evaluation of everolimus eluting coronary stents in the treatment of patients with ST-segment elevation myocardial infarction).
    Brugaletta S; Gori T; Low AF; Tousek P; Pinar E; Gomez-Lara J; Scalone G; Schulz E; Chan MY; Kocka V; Hurtado J; Gomez-Hospital JA; Münzel T; Lee CH; Cequier A; Valdés M; Widimsky P; Serruys PW; Sabaté M
    JACC Cardiovasc Interv; 2015 Jan; 8(1 Pt B):189-197. PubMed ID: 25616924
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of admission platelet volume indices for in-hospital major adverse cardiovascular events in acute ST-segment elevation myocardial infarction.
    Celik T; Kaya MG; Akpek M; Gunebakmaz O; Balta S; Sarli B; Duran M; Demirkol S; Uysal OK; Oguzhan A; Gibson CM
    Angiology; 2015 Feb; 66(2):155-62. PubMed ID: 24301422
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between ST-segment recovery and clinical outcomes after primary percutaneous coronary intervention: the HORIZONS-AMI ECG substudy report.
    Farkouh ME; Reiffel J; Dressler O; Nikolsky E; Parise H; Cristea E; Baran DA; Dizon J; Merab JP; Lansky AJ; Mehran R; Stone GW
    Circ Cardiovasc Interv; 2013 Jun; 6(3):216-23. PubMed ID: 23652600
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-term outcome after drug-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction: 5 years follow-up from the randomized DEDICATION trial (Drug Elution and Distal Protection in Acute Myocardial Infarction).
    Holmvang L; Kelbæk H; Kaltoft A; Thuesen L; Lassen JF; Clemmensen P; Kløvgaard L; Engstrøm T; Bøtker HE; Saunamäki K; Krusell LR; Jørgensen E; Tilsted HH; Christiansen EH; Ravkilde J; Køber L; Kofoed KF; Terkelsen CJ; Helqvist S
    JACC Cardiovasc Interv; 2013 Jun; 6(6):548-53. PubMed ID: 23683734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of mean platelet volume with angiographic thrombus burden and short-term mortality in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
    Lai HM; Xu R; Yang YN; Ma YT; Li XM; Zhao Q; Chen QJ; Zhai H; Liu F; Chen BD
    Catheter Cardiovasc Interv; 2015 Mar; 85 Suppl 1():724-33. PubMed ID: 25630273
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of stress hyperglycemia on in-hospital stent thrombosis and prognosis in nondiabetic patients with ST-segment elevation myocardial infarction undergoing a primary percutaneous coronary intervention.
    Zhang JW; Zhou YJ; Cao SJ; Yang Q; Yang SW; Nie B
    Coron Artery Dis; 2013 Aug; 24(5):352-6. PubMed ID: 23835666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of renal failure on all-cause mortality and other outcomes in patients treated by percutaneous coronary intervention.
    Loncar G; Barthelemy O; Berman E; Kerneis M; Petroni T; Payot L; Choussat R; Silvain J; Collet JP; Helft G; Montalescot G; Le Feuvre C
    Arch Cardiovasc Dis; 2015 Nov; 108(11):554-62. PubMed ID: 26184868
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Impact of Timing of Ischemic and Hemorrhagic Events on Mortality After Percutaneous Coronary Intervention: The ADAPT-DES Study.
    Brener SJ; Kirtane AJ; Stuckey TD; Witzenbichler B; Rinaldi MJ; Neumann FJ; Metzger DC; Henry TD; Cox DA; Duffy PL; Mazzaferri EL; Mehran R; Parvataneni R; Brodie BR; Stone GW
    JACC Cardiovasc Interv; 2016 Jul; 9(14):1450-7. PubMed ID: 27372190
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Predictors of adverse events among patients undergoing primary percutaneous coronary intervention: insights from a pooled analysis of the COMFORTABLE AMI and EXAMINATION trials.
    Taniwaki M; Stefanini GG; Räber L; Brugaletta S; Cequier A; Heg D; Iñiguez A; Kelbæk H; Serra A; Ostoijic M; Hernandez-Antolin R; Baumbach A; Blöchlinger S; Jüni P; Mainar V; Sabate M; Windecker S
    EuroIntervention; 2015 Aug; 11(4):391-8. PubMed ID: 25042419
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prediction of 1-year mortality in patients with acute coronary syndromes undergoing percutaneous coronary intervention: validation of the logistic clinical SYNTAX (Synergy Between Percutaneous Coronary Interventions With Taxus and Cardiac Surgery) score.
    Farooq V; Vergouwe Y; Généreux P; Bourantas CV; Palmerini T; Caixeta A; Garcìa-Garcìa HM; Diletti R; Morel MA; McAndrew TC; Kappetein AP; Valgimigli M; Windecker S; Dawkins KD; Steyerberg EW; Serruys PW; Stone GW
    JACC Cardiovasc Interv; 2013 Jul; 6(7):737-45. PubMed ID: 23866185
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The neutrophil-to-lymphocyte ratio is associated with bare-metal stent restenosis in STEMI patients treated with primary PCI.
    Bolca O; Güngör B; Özcan KS; Karadeniz FÖ; Sungur A; Köroğlu B; Bakhshyaliyev N; Yelgeç NS; Karataş B; İpek G; Yilmaz H; Öztürk R
    Coron Artery Dis; 2015 Aug; 26(5):402-8. PubMed ID: 25919903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of 3-dimensional bifurcation angle on 5-year outcome of patients after percutaneous coronary intervention for left main coronary artery disease: a substudy of the SYNTAX trial (synergy between percutaneous coronary intervention with taxus and cardiac surgery).
    Girasis C; Farooq V; Diletti R; Muramatsu T; Bourantas CV; Onuma Y; Holmes DR; Feldman TE; Morel MA; van Es GA; Dawkins KD; Morice MC; Serruys PW
    JACC Cardiovasc Interv; 2013 Dec; 6(12):1250-60. PubMed ID: 24355115
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.